Moleculin Biotech Debt to Equity Ratio Analysis

Moleculin Biotech Inc (MBRX)

2.45 0.00 (0.00%) USD | NASDAQ | Nov 04, 16:00

2.43 -0.02 (-0.82%) After-Hours: 20:00

Debt to Equity Ratio Chart

Historical Debt to Equity Ratio Data

View and export this data back to . Upgrade now.

Date	Value

Debt to Equity Ratio Definition

The debt to equity ratio measures the (Long Term Debt + Current Portion of Long Term Debt) / Total Shareholders' Equity. This metric is useful when analyzing the health of a company's balance sheet.

Read full definition.

Debt to Equity Ratio Range, Past 5 Years

Minimum

Maximum

Average

Median

Debt to Equity Ratio Benchmarks

Agilent Technologies Inc	0.4967
Seelos Therapeutics Inc	--
Cara Therapeutics Inc	0.00
Citius Pharmaceuticals Inc	--
NovaBay Pharmaceuticals Inc	-1.128

Debt to Equity Ratio Related Metrics

Total Assets (Quarterly)	25.58M
Total Liabilities (Quarterly)	7.87M
Shareholders Equity (Quarterly)	17.70M